We're MiLaboratories, the team behind MiXCR and Platforma.bio. Our tools are cited in thousands of papers and used in the published methods of approved cancer immunotherapies and the COVID vaccines that reached millions of people. 5 of the top 10 pharma companies run discovery programs on Platforma today. Our goal is 10 of 10 by year-end.

We're hiring 4–5 engineers in the next 90 days to get us there.

ABOUT PLATFORMA

MiXCR is the global standard for immune-repertoire analysis. Platforma.bio is the operating system we're building on top of it — turning bioinformatics into self-serve, interoperable blocks so biologists can move from raw sequencing data to therapeutic candidates without writing pipeline glue code. Our customers are pharma scientists running real discovery programs against real targets. The next paper that cites us could be the next drug.

ABOUT THIS ROLE

We made a decision that's reshapi...